Recent Posts

• Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
• Northwestern Study Looks at How Megalibraries Could Outperform Self-Driving Labs When it Comes to Materials Discovery
• ONE Bow River Invests in PteroDynamics to Accelerate VTOL Drone and Autonomous Aircraft Growth
• PteroDynamics Awarded Contract by Royal Australian Navy for Transwing VTOL Unmanned Aircraft Systems
• Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program